| Time | Topics | Speaker/s |
|
14:30
-
14:35
|
Intravitreal Injection of a Rho-kinase Inhibitor (Fasudil) Combined With Bevacizumab Versus Bevacizumab Monotherapy for Diabetic Macular Edema; a Randomized Clinical Trial
|
Ramin Nourinia, MD
|
|
14:37
-
14:42
|
Comparison of Two Doses of Intravitreal ziv-aflibercept (IVZ) vs Bevacizumab (IVB) for Treatment of Diabetic Macular Edema
|
Ahmadreza Baghi, MD
|
|
14:44
-
14:49
|
Intravitreal Diclofenac plus Bevacizumab Versus Bevacizumab Alone in Treatment-naive Diabetic Macular Edema: a Randomized Double-blind Clinical Trial
|
Seyed Ali Sonbolestan, MD
|
|
14:51
-
14:56
|
Topical Ketorolac Plus Intravitreal Bevacizumab Versus Intravitreal Bevacizumab in the Treatment of Diabetic Macular Edema, Prospective Placebo Controlled Randomized Trial
|
Homayoun Nikkhah, MD
|
|
14:58
-
15:03
|
Effects of Fatigue on Image Quality of Optical Coherence Tomography Angiography
|
Mojtaba Abrishami, MD
|
|
15:05
-
15:10
|
Short-term Safety and Efficacy of Ziv-aflibercept in Patients With Intraocular Vascular Diseases
|
Kamran Hodjat Jalali, MD
|
|
15:12
-
15:17
|
Incidence and Risk Factors of Retinopathy of Prematurity in Mashhad , Iran
|
Seyedeh Maryam Hosseini, MD
|
|
15:22
-
15:27
|
Effects of Topical Anesthesia on Image Quality of Optical Coherence Tomography Angiography: A Contralateral Eye Study
|
Mojtaba Abrishami, MD
|
|
15:29
-
15:34
|
Relation of Changes of Subfoveal Choroidal Thickness( SCT) With the Visual and Anatomical Outcomes of the Treatment of Diabetic Macular Edema With Ziv_Aflibercept
|
Siamak Moradian, MD
|
|
15:36
-
15:41
|
Efficacy of Intravitreal Bevacizumab Monotherapy in Retinopathy of Prematurity
|
Seyedeh Maryam Hosseini, MD
|
|
15:43
-
15:48
|
Quantitative Measurement of Vascular Density and Flow Using Optical Coherence Tomography Angiography in Patients With Uveitis Associated With Posterior Pole Vasculitis.
|
Mir Ataollah Salabati, MD
|
|
15:50
-
15:55
|
Quantitative Measurement of Vascular Density and Flow Using Optical Coherence Tomography Angiography in Patients With CRVO.
|
Kianosh Shahraki, MD
|
|
15:55
-
16:00
|
Questions and Answers
|
|